Advertisement
Screener

Septerna, Inc. (SEPN) Material Contracts

Septerna, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-05-11: Form 10-Q; Exhibit 10.1; Description Amended and Restated Non-Employee Director Compensation Policy, effective March 18, 2026.
  • 2026-03-09: Form 10-K; Exhibit 10.20; Description Employment Agreement, by and between the Registrant and Mark Wilson, dated as of January 6, 2026.
  • 2025-11-10: Form 10-Q; Exhibit 10.1; Description Amended and Restated Non-Employee Director Compensation Policy.
  • 2025-08-11: Form 10-Q; Exhibit 10.1; Description Novo Collaboration Agreement, between the Registrant and Novo Nordisk A/S, dated as of May 13, 2025..
FiledFormExhibitDescription
2026-05-1110-Q10.1Amended and Restated Non-Employee Director Compensation Policy, effective March 18, 2026
2026-03-0910-K10.20Employment Agreement, by and between the Registrant and Mark Wilson, dated as of January 6, 2026
2025-11-1010-Q10.1Amended and Restated Non-Employee Director Compensation Policy
2025-08-1110-Q10.1Novo Collaboration Agreement, between the Registrant and Novo Nordisk A/S, dated as of May 13, 2025.
2025-01-068-K10.1Offer Letter, by and between the Company and Gil M. Labrucherie, dated as of December 6, 2024.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xencor Inc (XNCR)United States$1.776B-7.33
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82